Merieux Equity Partners (MxEP) has announced the sale of GTP Bioways, a French Contract Developing and Manufacturing Organisation (CDMO) specializing in innovative medicines, to the Italian company Olon Group, which is a global leader in active pharmaceutical ingredients (APIs). The agreement sees Merieux Participations 3, part of MxEP, divesting its stake in GTP Bioways. The details of the financial transaction have not been disclosed.

Pharmaceuticals, Private Equity,France, Italy

Mérieux Equity Partners announces the sale of the French Contract Developing and Manufacturing Organisation GTP Bioways to the Italian company Olon Group